Answer
Finerenone selectively antagonises the mineralocorticoid receptor, forming a receptor–ligand complex that blocks recruitment of transcriptional coactivators implicated in the expression of pro-inflammatory and pro-fibrotic mediators.
Sources for this answer
- Kerendia 10 mg film coated tabletsBayer plc · emc · SmPC §5.1 Pharmacodynamic properties · Version 3Document updated
Sources checked